Praxbind Description



Boehringer Ingelheim


Zuellig Pharma
Full Prescribing Info
Each mL of solution for injection/infusion contains 50 mg idarucizumab.
Each vial contains 2.5 g idarucizumab in 50 mL.
Idarucizumab is produced by recombinant DNA technology in Chinese Hamster Ovary cells.
Excipients/Inactive Ingredients: Sodium acetate trihydrate, acetic acid, sorbitol, polysorbate 20, water for injection.
Excipients with known effect: Each 50 mL vial contains 2 g sorbitol and 25 mg sodium (see Precautions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in